Biohaven Pharmaceuticals, Inc.

CT · United States · Reporting entity ID 100000806824

Total reported 2019–2025

$48.6M

#177 of 2,960 reporting companies — 0.1% of all reported industry payments

$13.7M in general payments across 188,414 records, plus $34.9M in research funding across 4,706 records.

How it breaks down

General payments $13,739,869

Research funding $34,896,216

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.